EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access

Endoscopic Posterior Nasal Neurectomy Versus Radiofrequency Ablation in Refractory Allergic Rhinitis: A 2‐Year Randomized Controlled Trial of Clinical Outcomes and Immunomodulatory Responses

Rui Zheng, Xuekun Huang, Shuo Wu iD, Zhaohui Shi iD, Kai Wang, Huijun Qiu, Tian Yuan, Chuanliang Zhao, Jianhui Zhao, Weihao Wang, Zhenhao Xiao, Jianfeng Liu und 2 weitere

International Forum of Allergy & Rhinology · 2026-08 · 16 (8) · 831-840

DOI: 10.1002/alr.70126 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 05.03.2026. Verfasst von Rui Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Endoscopy, Radiofrequency Ablation, Rhinitis, Allergic, Nose. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Medical Scientific Research Foundation of Guangdong Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endoscopic posterior nasal nerve (PNN) neurectomy and temperature‐controlled radiofrequency ablation are validated interventions for medication‐refractory allergic rhinitis (AR), but direct comparisons of their long‐term efficacy, safety, and mechanisms remain lacking.

Methods

In this prospective, multicenter, randomized, patient‐blinded study, 174 adults with moderate‐to‐severe persistent AR were allocated to PNN neurectomy ( n = 89) or ablation ( n = 85). The primary endpoint was the percentage of participants achieving the minimal clinically important difference (MCID) for the 24‐h reflective total nasal symptom score (rTNSS) at 24 months.

Results

The rTNSS MCID responder rate at 24 months was 86.5% (95% confidence interval [CI], 80.0–95.0%) in the neurectomy group and 84.9% (95% CI, 78.0–94.0%) in the ablation group, with no significant between‐group difference ( p = 0.453). Both groups demonstrated substantial and parallel improvements in quality of life. Neurectomy provided greater and more durable control of rhinorrhea (1–24 months, all p < 0.05), nasal congestion (24 months, p < 0.001), and nasal itching (24 months, p = 0.046), alongside a greater reduction in unilateral nasal resistance (right side, p = 0.014). Both groups showed convergent systemic neuroimmune reprogramming at 1 year, with suppression of substance P, interleukin (IL)‐31, IL‐33, IL‐4, IL‐13, and IL‐6, and increased transforming growth factor‐β (TGF‐β)and immunoglobulin G4 (IgG4). No serious adverse events occurred; mild transitory events were reported only with neurectomy (3.4%).

Conclusion

Both techniques are effective and safe for refractory AR over 2 years. Although overall outcomes are comparable, neurectomy offers superior and sustained control of rhinorrhea, nasal congestion, and nasal itching. Treatment can be individualized based on symptom profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndoscopyRadiofrequency AblationRhinitis, AllergicNoseDenervationHumansFemaleMaleAdultTreatment OutcomeMiddle AgedProspective StudiesQuality of LifeYoung Adult

Stichwörter der Autor:innen

allergic rhinitisneurectomyposterior nasal nerveradiofrequency neurolysis

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Department of Allergy, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Key Laboratory of Airway Inflammatory Disease Research and Innovative Technology Translation, Guangzhou, China.
  • Department of Otolaryngology, First People's Hospital of Foshan, Foshan, China.
  • Department of Otolaryngology Head and Neck Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of Otolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing, China.

ORCID-Profile: Shuo Wu, Zhaohui Shi, Shaoqing Yu, Qintai Yang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Medical Scientific Research Foundation of Guangdong Province of China
  • Science and Technology Projects in Guangzhou
  • Science and Technology Projects in Shenzhen

Zitieren

APA

Zheng, R., Huang, X., Wu, S., Shi, Z., Wang, K., Qiu, H., Yuan, T., Zhao, C., Zhao, J., Wang, W., Xiao, Z., Liu, J., Yu, S., & Yang, Q. (2026). Endoscopic Posterior Nasal Neurectomy Versus Radiofrequency Ablation in Refractory Allergic Rhinitis: A 2‐Year Randomized Controlled Trial of Clinical Outcomes and Immunomodulatory Responses. International Forum of Allergy & Rhinology, 16(8), 831-840. https://doi.org/10.1002/alr.70126

Vancouver

Zheng R, Huang X, Wu S, Shi Z, Wang K, Qiu H, et al. Endoscopic Posterior Nasal Neurectomy Versus Radiofrequency Ablation in Refractory Allergic Rhinitis: A 2‐Year Randomized Controlled Trial of Clinical Outcomes and Immunomodulatory Responses. International Forum of Allergy & Rhinology. 2026;16(8):831-840. doi:10.1002/alr.70126

BibTeX
@article{Zheng2026,
  author = {Zheng, Rui and Huang, Xuekun and Wu, Shuo and Shi, Zhaohui and Wang, Kai and Qiu, Huijun and Yuan, Tian and Zhao, Chuanliang and Zhao, Jianhui and Wang, Weihao and Xiao, Zhenhao and Liu, Jianfeng and Yu, Shaoqing and Yang, Qintai},
  title = {Endoscopic Posterior Nasal Neurectomy Versus Radiofrequency Ablation in Refractory Allergic Rhinitis: A 2‐Year Randomized Controlled Trial of Clinical Outcomes and Immunomodulatory Responses},
  journal = {International Forum of Allergy & Rhinology},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {831--840},
  doi = {10.1002/alr.70126}
}
Kostenlos starten →